Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

Biodesix (BDSX) Long-Term Debt Repayments (2021 - 2026)

Biodesix filings provide 6 years of Long-Term Debt Repayments readings, the most recent being $5000.0 for Q1 2026.

On a quarterly basis, Long-Term Debt Repayments fell 28.57% to $5000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $19000.0, a 57.78% decrease, with the full-year FY2025 number at $21000.0, down 58.82% from a year prior.
Long-Term Debt Repayments hit $5000.0 in Q1 2026 for Biodesix, roughly flat from $5000.0 in the prior quarter.
In the past five years, Long-Term Debt Repayments ranged from a high of $23.6 million in Q4 2022 to a low of $4000.0 in Q3 2025.
Median Long-Term Debt Repayments over the past 5 years was $12000.0 (2023), compared with a mean of $1.7 million.
The widest YoY moves for Long-Term Debt Repayments: up 100366.67% in 2022, down 99.96% in 2022.
Biodesix's Long-Term Debt Repayments stood at $23.6 million in 2022, then tumbled by 99.94% to $13000.0 in 2023, then changed by 0.0% to $13000.0 in 2024, then crashed by 61.54% to $5000.0 in 2025, then changed by 0.0% to $5000.0 in 2026.
The last three reported values for Long-Term Debt Repayments were $5000.0 (Q1 2026), $5000.0 (Q4 2025), and $4000.0 (Q3 2025) per Business Quant data.